Kyle Rose
Stock Analyst at Canaccord Genuity
(2.67)
# 2,176
Out of 5,076 analysts
114
Total ratings
53.26%
Success rate
13.81%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $32.72 | -17.48% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $310.83 | +4.24% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $372.32 | +16.83% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $89.79 | -20.93% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $29.36 | +141.83% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.30 | +53.85% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.49 | +571.14% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $21.96 | +0.18% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $63.52 | +136.15% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $2.66 | +10,050.38% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $18.87 | +43.08% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.13 | +1,227.43% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $28.53 | -47.42% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $156.94 | -22.26% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $5.82 | -31.27% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.61 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $94.76 | +31.91% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $32.72
Upside: -17.48%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $310.83
Upside: +4.24%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $372.32
Upside: +16.83%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $89.79
Upside: -20.93%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $29.36
Upside: +141.83%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.30
Upside: +53.85%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $21.96
Upside: +0.18%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $63.52
Upside: +136.15%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $2.66
Upside: +10,050.38%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $18.87
Upside: +43.08%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.13
Upside: +1,227.43%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $28.53
Upside: -47.42%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $156.94
Upside: -22.26%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $5.82
Upside: -31.27%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.61
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $94.76
Upside: +31.91%